Mitigating COVID‑19 variant spread by leveraging social psychological and neurobiological markers to optimize public health communications during the first vaccine rollout.
COVID-19 Variant Supplement – Development of small interfering RNAs (siRNAs) for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
COVID-19 Variant Supplement – Development and implementation of rapid metagenomic sequencing coupled with isothermal amplification point of care testing for viral diagnostics
The Randomized Embedded Multifactorial Adaptive Platform Trial in Community-acquired Pneumonia (REMAP-CAP): Building an International Research Response to Variant COVID-19
